Adela Serrano

943 total citations
18 papers, 765 citations indexed

About

Adela Serrano is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Small Animals. According to data from OpenAlex, Adela Serrano has authored 18 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 2 papers in Small Animals. Recurrent topics in Adela Serrano's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Adela Serrano is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Adela Serrano collaborates with scholars based in Spain, Switzerland and Venezuela. Adela Serrano's co-authors include Julio Cortijo, Javier Milara, Teresa Peiró, Esteban Morcillo, Gustavo Alberto San Juan, Rafael Navarro, Amadeu Gavaldà, A Morell, R. Guijarro and Miquel Armengot‐Carbó and has published in prestigious journals such as The FASEB Journal, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Adela Serrano

17 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adela Serrano Spain 13 435 262 199 68 68 18 765
Yilin Zhao China 14 184 0.4× 329 1.3× 102 0.5× 91 1.3× 137 2.0× 19 681
Kazuyuki Chibana Japan 12 295 0.7× 125 0.5× 450 2.3× 42 0.6× 185 2.7× 29 705
Lijun Mao China 13 181 0.4× 197 0.8× 79 0.4× 49 0.7× 89 1.3× 26 508
M Corbel France 7 201 0.5× 118 0.5× 107 0.5× 79 1.2× 83 1.2× 13 597
Qutayba Hamid Canada 14 129 0.3× 128 0.5× 190 1.0× 46 0.7× 285 4.2× 15 616
Jacob M. Tobolewski United States 10 359 0.8× 144 0.5× 99 0.5× 20 0.3× 98 1.4× 10 698
Yihe Wu China 13 98 0.2× 275 1.0× 75 0.4× 64 0.9× 71 1.0× 42 631
Norifumi Nakamura Japan 16 73 0.2× 311 1.2× 67 0.3× 62 0.9× 25 0.4× 45 785
Yinshan Fang United States 11 191 0.4× 182 0.7× 72 0.4× 46 0.7× 42 0.6× 23 473
Athina Giagini Greece 14 247 0.6× 169 0.6× 47 0.2× 102 1.5× 50 0.7× 23 635

Countries citing papers authored by Adela Serrano

Since Specialization
Citations

This map shows the geographic impact of Adela Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adela Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adela Serrano more than expected).

Fields of papers citing papers by Adela Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adela Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adela Serrano. The network helps show where Adela Serrano may publish in the future.

Co-authorship network of co-authors of Adela Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Adela Serrano. A scholar is included among the top collaborators of Adela Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adela Serrano. Adela Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pintado‐Berninches, Laura, Ana Montes‐Worboys, Cristina Manguán-García, et al.. (2021). GSE4‐loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage. The FASEB Journal. 35(3). e21422–e21422. 10 indexed citations
2.
Morell, A, et al.. (2017). Roflumilast N- oxide combined with sildenafil reverses cellular remodeling on IPF models. OA4833–OA4833. 1 indexed citations
3.
Serrano, Adela, et al.. (2015). Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test. Current Eye Research. 41(7). 890–896. 13 indexed citations
4.
Ballester, Beatriz, et al.. (2015). Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients. PA4902–PA4902. 3 indexed citations
5.
Milara, Javier, et al.. (2014). Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cellsin vitro. COPD Journal of Chronic Obstructive Pulmonary Disease. 12(3). 327–338. 18 indexed citations
6.
Milara, Javier, Teresa Peiró, Miquel Armengot‐Carbó, et al.. (2014). Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 135(2). 470–476. 63 indexed citations
7.
Milara, Javier, Teresa Peiró, Adela Serrano, et al.. (2014). Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulmonary Pharmacology & Therapeutics. 28(2). 138–148. 50 indexed citations
8.
Milara, Javier, Teresa Peiró, Adela Serrano, & Julio Cortijo. (2013). Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax. 68(5). 410–420. 252 indexed citations
9.
Milara, Javier, Patricia Almudéver, Teresa Peiró, et al.. (2013). Bafetinib inhibits functional responses of human eosinophils in vitro. European Journal of Pharmacology. 715(1-3). 172–180. 4 indexed citations
10.
Milara, Javier, Adela Serrano, Teresa Peiró, et al.. (2012). Aclidinium inhibits cigarette smoke-induced lung fibroblast-to-myofibroblast transition. European Respiratory Journal. 41(6). 1264–1274. 36 indexed citations
11.
Milara, Javier, Rafael Navarro, Gustavo Alberto San Juan, et al.. (2011). Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax. 67(2). 147–156. 143 indexed citations
12.
Milara, Javier, Gustavo Alberto San Juan, Teresa Peiró, Adela Serrano, & Julio Cortijo. (2011). Neutrophil Activation in Severe, Early-Onset COPD Patients versus Healthy Non-Smoker Subjects in vitro: Effects of Antioxidant Therapy. Respiration. 83(2). 147–158. 32 indexed citations
13.
Milara, Javier, Adela Serrano, Teresa Peiró, et al.. (2011). Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax. 67(3). 229–237. 57 indexed citations
14.
Milara, Javier, Manuel Mata, Adela Serrano, et al.. (2010). Extracellular calcium-sensing receptor mediates human bronchial epithelial wound repair. Biochemical Pharmacology. 80(2). 236–246. 21 indexed citations
15.
Milara, Javier, Gustavo Alberto San Juan, J.L. Ortiz, et al.. (2010). Cigarette smoke-induced pulmonary endothelial dysfunction is partially suppressed by sildenafil. European Journal of Pharmaceutical Sciences. 39(5). 363–372. 25 indexed citations
16.
Serrano, José Antonio, et al.. (1976). The cytochemical demonstration of prostatic acid phosphatase using a new substrate, phosphorylcholine.. Journal of Histochemistry & Cytochemistry. 24(10). 1046–1056. 24 indexed citations
17.
Serrano, José Antonio, et al.. (1972). Physiological, Chemical and Ultrastructural Characteristics of Corynebacterium rubrum. Journal of General Microbiology. 70(2). 339–349. 12 indexed citations
18.
Serrano, Adela, et al.. (1971). Ultrastructure of Nocardia Astcroides. Proceedings annual meeting Electron Microscopy Society of America. 29. 250–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yilin Zhao Breakdown of academic impact, for papers by Kazuyuki Chibana Breakdown of academic impact, for papers by Lijun Mao Breakdown of academic impact, for papers by M Corbel Breakdown of academic impact, for papers by Qutayba Hamid Breakdown of academic impact, for papers by Jacob M. Tobolewski Breakdown of academic impact, for papers by Yihe Wu Breakdown of academic impact, for papers by Norifumi Nakamura Breakdown of academic impact, for papers by Yinshan Fang Breakdown of academic impact, for papers by Athina Giagini
Rankless by CCL
2026